These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 35428593)

  • 1. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Jiang C; Zhang S; Qiao K; Xiu Y; Yu X; Huang Y
    Clin Breast Cancer; 2022 Jul; 22(5):424-438. PubMed ID: 35428593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
    Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
    Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 4. Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
    Dong J; Sun Q; Pan Y; Lu N; Han X; Zhou Q
    BMC Cancer; 2021 Jun; 21(1):700. PubMed ID: 34126950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Capacity of Systemic Inflammation Response Index, Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Hypopharyngeal Squamous Cell Carcinoma.
    Wang T; Lin H; Hsueh C; Lau HC; Zhou J; Gong H; Tao L; Zhou L; Wu C
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):453-463. PubMed ID: 35709701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    Cancer Manag Res; 2020; 12():1543-1567. PubMed ID: 32184659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.
    Zhang YX; Shen ZY; Jia YC; Guo X; Guo XS; Xing Y; Tian SJ
    J Inflamm Res; 2023; 16():3619-3630. PubMed ID: 37641703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.
    Zheng C; Ye S; Liu W; Diao M; Li L
    Front Oncol; 2023; 13():1276175. PubMed ID: 37901310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
    Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
    Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
    Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients.
    Zhang Y; Xing Z; Zhou K; Jiang S
    Clin Interv Aging; 2021; 16():1997-2007. PubMed ID: 34880606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.
    Wang H; Huang Z; Xu B; Zhang J; He P; Gao F; Zhang R; Huang X; Shan M
    Clin Transl Oncol; 2024 Jun; 26(6):1467-1479. PubMed ID: 38190034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.
    Li Q; Yu L; Yang P; Hu Q
    Cancer Manag Res; 2021; 13():6799-6810. PubMed ID: 34512020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram.
    He Q; Li L; Ren Q
    Front Oncol; 2021; 11():671811. PubMed ID: 34055639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
    Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
    Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients.
    Peng Y; Chen R; Qu F; Ye Y; Fu Y; Tang Z; Wang Y; Zong B; Yu H; Luo F; Liu S
    Cancer Biol Ther; 2020; 21(2):189-196. PubMed ID: 31684807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation.
    Chuang HC; Tsai MH; Lin YT; Chou MH; Huang TL; Chiu TJ; Lu H; Fang FM; Chien CY
    Cancer Manag Res; 2020; 12():9013-9021. PubMed ID: 33061596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.
    Chen Y; Jin M; Shao Y; Xu G
    Dis Markers; 2019; 2019():4659048. PubMed ID: 31781301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.